DE68923913D1 - Neplanocinderivate. - Google Patents

Neplanocinderivate.

Info

Publication number
DE68923913D1
DE68923913D1 DE68923913T DE68923913T DE68923913D1 DE 68923913 D1 DE68923913 D1 DE 68923913D1 DE 68923913 T DE68923913 T DE 68923913T DE 68923913 T DE68923913 T DE 68923913T DE 68923913 D1 DE68923913 D1 DE 68923913D1
Authority
DE
Germany
Prior art keywords
neplanocin derivatives
neplanocin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68923913T
Other languages
English (en)
Other versions
DE68923913T2 (de
Inventor
Esa T Jarvi
James R Mccarthy
Nellikunja Jaya Prakash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE68923913D1 publication Critical patent/DE68923913D1/de
Publication of DE68923913T2 publication Critical patent/DE68923913T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE68923913T 1988-06-20 1989-06-20 Neplanocinderivate. Expired - Fee Related DE68923913T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20924588A 1988-06-20 1988-06-20

Publications (2)

Publication Number Publication Date
DE68923913D1 true DE68923913D1 (de) 1995-09-28
DE68923913T2 DE68923913T2 (de) 1996-01-11

Family

ID=22777970

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68923913T Expired - Fee Related DE68923913T2 (de) 1988-06-20 1989-06-20 Neplanocinderivate.

Country Status (20)

Country Link
EP (1) EP0347852B1 (de)
JP (1) JP2967998B2 (de)
KR (1) KR0139808B1 (de)
CN (1) CN1040031A (de)
AR (1) AR244688A1 (de)
AT (1) ATE126800T1 (de)
AU (1) AU612854B2 (de)
CA (1) CA1339646C (de)
DE (1) DE68923913T2 (de)
DK (1) DK301789A (de)
ES (1) ES2078904T3 (de)
FI (1) FI91156C (de)
GR (1) GR3017794T3 (de)
HU (1) HUT50194A (de)
IE (1) IE66980B1 (de)
IL (1) IL90639A (de)
NO (1) NO168108C (de)
NZ (1) NZ229596A (de)
PT (1) PT90903B (de)
ZA (1) ZA894534B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521162A (en) * 1987-08-26 1996-05-28 Merrell Pharmaceuticals Inc. Aristeromycin analogues of 4',5'-didehydro-5'-fluoro-adenosine and methods of treating neoplastic and viral disease conditions
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
HU204843B (en) * 1988-09-27 1992-02-28 Merrell Dow Pharma Process for producing 2'-halogen-methylidene adenosine derivatives and pharmaceutical compositions comprising same
JPH0421682A (ja) * 1990-05-11 1992-01-24 Asahi Chem Ind Co Ltd ２―フルオロネプラノシンａおよびその製造法
GB9205071D0 (en) * 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
US5399580A (en) * 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9600142D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
DE60024257T2 (de) * 1999-06-09 2006-07-20 Anticancer Inc., San Diego Modulatoren der methylierung zur kontrolle von bakterieller virulenz
SG182849A1 (en) 2003-04-25 2012-08-30 Gilead Sciences Inc Antiviral phosphonate analogs
EP2258376B1 (de) 2004-07-27 2019-02-27 Gilead Sciences, Inc. Phosphonat Analoga von HIV Inhibitor Verbindungen
US8658617B2 (en) 2008-07-08 2014-02-25 Gilead Sciences, Inc. Salts of HIV inhibitor compounds
US20110237606A1 (en) * 2008-09-26 2011-09-29 Agency Of Science, Technology And Research 3-Deazaneplanocin Derivatives
PL3661937T3 (pl) 2017-08-01 2021-12-20 Gilead Sciences, Inc. Formy krystaliczne ((s)-((((2r,5r)-5-(6-amino-9h-puryn-9-ylo)-4-fluoro-2,5-dihydrofuran-2-ylo)oksy)metylo)(fenoksy)fosforylo)-l-alaninianu etylu (gs-9131) do leczenia zakażeń wirusowych

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU192741B (en) * 1978-05-25 1987-07-28 Toyo Jozo Kk Process for producing new neplanocin antibiotics
DE3148363A1 (de) * 1980-12-12 1982-09-16 Toyo Jozo K.K., Shizuoka Neplanocin a-derivate
US4797479A (en) * 1985-04-15 1989-01-10 Toyo Jozo Kabushiki Kaisha Nucleoside-phospholipid conjugate
EP0262876B1 (de) * 1986-09-27 1992-04-29 Toyo Jozo Kabushiki Kaisha Nukleosid-Phospholipid-Konjugat

Also Published As

Publication number Publication date
FI91156B (fi) 1994-02-15
DE68923913T2 (de) 1996-01-11
CN1040031A (zh) 1990-02-28
IE891986L (en) 1989-12-20
IE66980B1 (en) 1996-02-21
EP0347852B1 (de) 1995-08-23
PT90903A (pt) 1989-12-29
DK301789A (da) 1989-12-21
AU612854B2 (en) 1991-07-18
CA1339646C (en) 1998-01-27
IL90639A (en) 1992-12-01
PT90903B (pt) 1994-12-30
EP0347852A3 (de) 1991-09-11
AR244688A1 (es) 1993-11-30
FI893003A0 (fi) 1989-06-19
ATE126800T1 (de) 1995-09-15
JPH0240369A (ja) 1990-02-09
GR3017794T3 (en) 1996-01-31
IL90639A0 (en) 1990-01-18
NO168108B (no) 1991-10-07
ES2078904T3 (es) 1996-01-01
HUT50194A (en) 1989-12-28
DK301789D0 (da) 1989-06-19
NO892543D0 (no) 1989-06-19
AU3651789A (en) 1989-12-21
FI91156C (fi) 1994-05-25
NZ229596A (en) 1990-12-21
KR910000734A (ko) 1991-01-30
JP2967998B2 (ja) 1999-10-25
NO168108C (no) 1992-01-15
ZA894534B (en) 1990-03-28
KR0139808B1 (ko) 1998-06-01
FI893003A (fi) 1989-12-21
EP0347852A2 (de) 1989-12-27
NO892543L (no) 1989-12-21

Similar Documents

Publication Publication Date Title
DE122004000043I1 (de) Carbostryril-Derivate.
ATE74125T1 (de) Didehydro-vitamin d3-derivate.
DE69008682D1 (de) Guanidinobenzolderivate.
DE58901056D1 (de) Dehydrocholecalciferolderivate.
DE68923913D1 (de) Neplanocinderivate.
DE3872153T2 (de) 25-hydroxy-vitamin-d3-derivate.
ATE124407T1 (de) Chromanderivate.
FI883963A (fi) Isoxazol- -karbolinderivat.
ATE116985T1 (de) Chromanderivate.
DE68911192D1 (de) Phosphonoalkylpurin-Derivate.
DE58903265D1 (de) Fluorcyclopropyl-derivate.
DE69005904D1 (de) Phenylpyrimidonderivate.
DE59000510D1 (de) N-phenyltetrahydroindazolderivate.
DE68913856D1 (de) Cycloalkylthiazol-Derivate.
DE59003499D1 (de) 3-Cyano-4-phenyl-pyrrol-Derivate.
DE3861208D1 (de) Hydroxyalkyl-triazolyl-derivate.
NO892714L (no) Substituerte azacykloheksylderivater.
DE58900371D1 (de) 3-cyano-4-phenyl-pyrrol-derivate.
DE3866371D1 (de) Diphenylaethylen-derivate.
DE69004991T2 (de) Diphenyldiacetylenderivate.
DE69001450D1 (de) Dihydroxynaphthalin-derivate.
DE3884482T2 (de) Thiapentanamid-Derivate.
DE3881146D1 (de) Thiazetidin-derivate.
DE3868364D1 (de) Ucy-1003-derivate.
DE3863447D1 (de) Aminoethylphosphinsaeure-derivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee